interlymph

WHAT IS INTERLYMPH?

The International Lymphoma Epidemiology Consortium (InterLymph) is an open scientific forum for epidemiologic research in lymphoproliferative disorders. Established in 2001, the Consortium is an international group of scientists who undertake research projects that pool data across studies to better understand lymphoma risk factors.

Find out more: http://epi.grants.cancer.gov/InterLymph/

WHAT ARE THE OBJECTIVES OF INTERLYMPH?

The objectives of InterLymph are to expand knowledge of lymphoma causes and survival through:

  • Fostering collaborations between researchers in different countries;
  • Providing a framework for the efficient conduct and publication of original data meta-analyses of relevant studies;
  • Providing a forum and framework for discussion, development and pursuit of new research directions; and
  • Supporting the development of early career researchers.

IN WHAT AREAS DOES INTERLYMPH FOCUS ITS WORK?

InterLymph consists of seven working groups.

  • Family Working Group
  • Genetics
  • Hodgkin Lymphoma
  • Immunology and Infection,
  • Lifestyle and Environment
  • Multiple Myeloma
  • Pathology and Survival

LEARN MORE ABOUT KEY FINDINGS FROM THE INTERLYMPH SCIENTIFIC MEETINGS.

2017
2015
2014
2013
2012
2011

 

Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe

WEIGH-IN WEDNESDAY

Were you offered support from a social worker or psychologist?

IN THE NODE

Updates

 

The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 03/27/18. Copyright © 2018 Lymphoma Coalition. All rights reserved.